Hotstocked Newsletters

Promoted Companies

PROMOTION HISTORY
SORT BY:

Endonovo Therapeutics, Inc. (ENDV)

Total paid for Promotions this month: $5,000
E-mails this Month: 3
Estimated Volume Generated: $0
Research Report on ENDV: Click to see
* The information presented is based on information for Oct , 2015

*** ENDV Has Traders on Jun 30, 2015 07:06

www.PennyStockAlerts.com does its best to bring you accurate information but errors may and sometimes do occur. Always do your own research before trading. PennyStockAlerts.com is not a licensed financial advisor.  This is a paid marketing newsletter which will state compensation, if any, for the specific company being marketed in the disclaimer at the end of this message.       Good morning everyone.   We've got a hot one today!!   The ...read more
Promoter: The Stock Psycho Paying Party: Meridian Ventures
Stocks covered: Compensation: Avg $ Volume for Period:
ENDV $15,000 UNKNOWN
Max Profit: 0.00 % Gain at close: Pending
www.PennyStockAlerts.com does its best to bring you accurate information but errors may and sometimes do occur. Always do your own research before trading. PennyStockAlerts.com is not a licensed financial advisor.  This is a paid marketing newsletter which will state compensation, if any, for the specific company being marketed in the disclaimer at the end of this message.       My Super Hot “POWER” Play is ENDV - Endonovo ...read more
Promoter: The Stock Psycho Paying Party: Meridian Ventures
Stocks covered: Compensation: Avg $ Volume for Period:
ENDV $15,000 UNKNOWN
Max Profit: 0.00 % Gain at close: Pending
www.DailyPennyStocks.com does its best to bring you accurate information but errors may and sometimes do occur. Always do your own research before trading. DailyPennyStocks.com is not a licensed financial advisor.  This is a paid marketing newsletter which will state compensation, if any, for the specific company being marketed in the disclaimer at the end of this message.     My Super Hot “POWER” Play is ENDV - Endonovo ...read more
Promoter: Darth Trader Paying Party: Meridian Ventures
Stocks covered: Compensation: Avg $ Volume for Period:
ENDV $15,000 UNKNOWN
Max Profit: 0.00 % Gain at close: Pending
                ENDV Announces Pre-clinical Testing Of Its Electroceutical Technology For Treating Liver Disease   Good Afternoon!   ENDV may just be on its way to biotech gold. The company which focuses on treatments for liver disease has announced pre-clinical trials for one of its applications.   Pre-clinical trials are an important part of the process of bringing ...read more
Promoter: DAMN GOOD PENNY PICKS Paying Party: Meridian Ventures
Stocks covered: Compensation: Avg $ Volume for Period:
ENDV $25,000 UNKNOWN
Max Profit: 6.02 % Gain at close: Pending
                  ENDV Announces Pre-clinical Testing Of Its Electroceutical Technology For Treating Liver Disease   Good Afternoon!   ENDV may just be on its way to biotech gold. The company which focuses on treatments for liver disease has announced pre-clinical trials for one of its applications.   Pre-clinical trials are an important part of the process ...read more
Promoter: PennyStock Buzz Paying Party: Meridian Ventures
Stocks covered: Compensation: Avg $ Volume for Period:
ENDV $25,000 UNKNOWN
Max Profit: 6.02 % Gain at close: Pending
              ENDV Announces Pre-clinical Testing Of Its Electroceutical Technology For Treating Liver Disease   Good Afternoon!   ENDV may just be on its way to biotech gold. The company which focuses on treatments for liver disease has announced pre-clinical trials for one of its applications.   Pre-clinical trials are an important part of the process of bringing ...read more
Promoter: Prepump Stocks Paying Party: Meridian Ventures
Stocks covered: Compensation: Avg $ Volume for Period:
ENDV $25,000 UNKNOWN
Max Profit: 6.02 % Gain at close: Pending
            ENDV Announces Pre-clinical Testing Of Its Electroceutical Technology For Treating Liver Disease   Good Afternoon!   ENDV may just be on its way to biotech gold. The company which focuses on treatments for liver disease has announced pre-clinical trials for one of its applications.   Pre-clinical trials are an important part of the process of bringing drugs to market ...read more
Promoter: PENNY PICKS Paying Party: Meridian Ventures
Stocks covered: Compensation: Avg $ Volume for Period:
ENDV $25,000 UNKNOWN
Max Profit: 6.02 % Gain at close: Pending
  ohai posted: " Endonovo Therapeutics (ENDV) is a biotechnology company developing off-the-shelf regenerative products that no longer require the injection of stem cells. Our first platform, Cell Free Therapeutics, harnesses the biological secretions of cells to create" Respond to this post by replying above this line   New post on The UnderValued Report™ Endonovo Therapeutics (ENDV) ...read more
Promoter: PennyStockWatchlists Paying Party: UNKNOWN
Stocks covered: Compensation: Avg $ Volume for Period:
ENDV Unknown compensation UNKNOWN
Max Profit: Pending Gain at close: Pending
First  << Last